Evidence map›Paper›PMID 26642243›Full record

ArticleNature genetics2016

Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.

Qing Zhou, Hongying Wang, Daniella M Schwartz, Monique Stoffels, Yong Hwan Park, Yuan Zhang, Dan Yang, Erkan Demirkaya, Masaki Takeuchi, Wanxia Li Tsai and 31 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Nature genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 347 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
347citing papers in PubMed, 2 pooled it
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

347 citing papers in PubMed, 2 syntheses or guidelines pooled it, 613 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Autosomal recessive A20 zinc finger 7 mutation is associated with early-onset lupus-like disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  7. Article
  8. Article
  9. How I Treat: Haploinsufficiency of A20.Journal of human immunity · 2026
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. [Haploinsufficiency of A20 in a family caused by a heterozygous deletion in theZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Article
  19. Article
  20. Article

287 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 11 institutions in 4 countries.

Qing ZhouInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Hongying WangInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Daniella M SchwartzMolecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.ORCID 0000-0002-1660-8438
Monique StoffelsInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Yong Hwan ParkInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Yuan ZhangGenetics and Pathogenesis of Allergy Section, National Institute of Allergy and Infectious Diseases, Laboratory of Allergic Diseases, Bethesda, Maryland, USA.
Dan YangLaboratory of Cardiovascular Regenerative Medicine, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
Erkan DemirkayaFMF Arthritis Vasculitis and Orphan Disease Research Center (FAVOR), Gulhane Military Medical Academy, Ankara, Turkey.
Masaki TakeuchiInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Wanxia Li TsaiTranslational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Jonathan J LyonsGenetics and Pathogenesis of Allergy Section, National Institute of Allergy and Infectious Diseases, Laboratory of Allergic Diseases, Bethesda, Maryland, USA.
Xiaomin YuGenetics and Pathogenesis of Allergy Section, National Institute of Allergy and Infectious Diseases, Laboratory of Allergic Diseases, Bethesda, Maryland, USA.
Claudia OuyangAutoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Celeste ChenInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
David T ChinInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Kristien ZaalLight Imaging Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Settara C ChandrasekharappaCancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, Bethesda, Maryland, USA.
Eric P HansonAutoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Zhen YuLaboratory of Cardiovascular Regenerative Medicine, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
James C MullikinNational Institute of Health Intramural Sequencing Center, National Human Genome Research Institute, Bethesda, Maryland, USA.
Sarfaraz A HasniSystemic Autoimmune Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Ingrid E WertzDepartment of Molecular Oncology, Genentech, Inc., San Francisco, California, USA.
Amanda K OmbrelloInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Deborah L StoneInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Patrycja HoffmannInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Anne JonesInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Beverly K BarhamInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Helen L LeavisDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Annet van Royen-KerkofDepartment of Pediatric Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Cailin SibleyDivision of Arthritis and Rheumatic Diseases, Oregon Health and Science University, Portland, Oregon, USA.
Ezgi D BatuDepartment of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey.
Ahmet GülDepartment of Internal Medicine, Istanbul University, Istanbul, Turkey.
Richard M SiegelAutoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Manfred BoehmLaboratory of Cardiovascular Regenerative Medicine, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
Joshua D MilnerGenetics and Pathogenesis of Allergy Section, National Institute of Allergy and Infectious Diseases, Laboratory of Allergic Diseases, Bethesda, Maryland, USA.
Seza OzenDepartment of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey.
Massimo GadinaTranslational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
JaeJin ChaeInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Ronald M LaxerDivision of Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Daniel L KastnerInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
Ivona AksentijevichInflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA.
National Human Genome Research Institute · USNational Institute of Arthritis and Musculoskeletal and Skin Diseases · USNational Institute of Allergy and Infectious Diseases · USNational Heart Lung and Blood Institute · USHacettepe University · TRUniversity Medical Center Utrecht · NLIstanbul University · TRMolecular Oncology (United States) · USOregon Health & Science University · USTurkish Armed Forces · TRUniversity of Toronto · CA

Funding

Inter- and Intra-Species Comparative SequencingZIBHG000196 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI THOMAS, JAMES · 2009 to 2025
$177.6M
Clinical Support Services for the NIAMS Intramural Research ProgramZIDAR041180 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$119.2M
Translational Immunology research: a support for clinical immunological researchZICAR041181 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI GADINA, MASSIMO · 2009 to 2025
$31.5M
Clinical Training in RheumatologyZIEAR041176 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$29.8M
Vascular remodeling in patients with rare genetic disordersZIAHL006077 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI BOEHM, MANFRED · 2010 to 2025
$22.9M
Genetics, Pathophysiology, and Treatment of Dominant Autoinflammatory DiseasesZIAHG200373 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI KASTNER, DANIEL · 2011 to 2024
$21.0M
NIAMS Light Imaging FacilityZICAR041186 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI RANDAZZO, DAVIDE · 2010 to 2025
$18.2M
Comparative Genomics Unit ResearchZIAHG200330 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI MULLIKIN, JAMES C · 2009 to 2022
$17.9M
NHGRI/DIR Genomics CoreZICHG200346 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI CHANDRASEKHARAPPA, SETTARA · 2010 to 2025
$14.5M
POSITIONAL CLONING OF THE MEN1 GENEZIAHG000029 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI CHANDRASEKHARAPPA, SETTARA · 2009 to 2025
$13.3M
Genetics, Natural History, and Pathophysiology of Behcet's DiseaseZIAHG200374 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI KASTNER, DANIEL · 2011 to 2020
$10.5M
TNF-receptors and programmed cell death in regulation of autoimmunityZIAAR041133 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI SIEGEL, RICHARD M · 2009 to 2019
$9.3M
Intramural NIH HHS Z99 HG999999NIAMS NIH HHS K23 AR068440
6 · The paper itself

Abstract

Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity. Herein we describe a new disease caused by high-penetrance heterozygous germline mutations in TNFAIP3, which encodes the NF-κB regulatory protein A20, in six unrelated families with early-onset systemic inflammation. The disorder resembles Behçet's disease, which is typically considered a polygenic disorder with onset in early adulthood. A20 is a potent inhibitor of the NF-κB signaling pathway. Mutant, truncated A20 proteins are likely to act through haploinsufficiency because they do not exert a dominant-negative effect in overexpression experiments. Patient-derived cells show increased degradation of IκBα and nuclear translocation of the NF-κB p65 subunit together with increased expression of NF-κB-mediated proinflammatory cytokines. A20 restricts NF-κB signals via its deubiquitinase activity. In cells expressing mutant A20 protein, there is defective removal of Lys63-linked ubiquitin from TRAF6, NEMO and RIP1 after stimulation with tumor necrosis factor (TNF). NF-κB-dependent proinflammatory cytokines are potential therapeutic targets for the patients with this disease.

Indexed as

MutationAge of OnsetDNA-Binding ProteinsFemaleHaploinsufficiencyHereditary Autoinflammatory DiseasesHumansI-kappa B KinaseI-kappa B ProteinsIntracellular Signaling Peptides and ProteinsMaleNF-kappa BNF-KappaB Inhibitor alphaNuclear Pore Complex ProteinsNuclear ProteinsPedigreeAGFG1 protein, humanDNA-Binding ProteinsI-kappa B KinaseI-kappa B ProteinsIKBKG protein, humanIntracellular Signaling Peptides and ProteinsNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanNuclear Pore Complex ProteinsNuclear ProteinsRNA-Binding ProteinsTNFAIP3 protein, humanTNF Receptor-Associated Factor 6Tumor Necrosis Factor alpha-Induced Protein 3

Identifiers

PMID26642243
PMCPMC4777523
OpenAlexW2194309244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.